AT418975T
Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof
Abstract
This record has no abstract on file.
Term
Term ended
Expired 13 October 2012, 13.9 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
81 members in 16 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 77974491 | United States of America | A |
Members81
| Document | Office | Kind | |
|---|---|---|---|
| IL103471D0 | Israel | D0 | |
| WO9307866A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2804592A | Australia | A | |
| WO9307866A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0567613A1 | European Patent Office (EPO) | A1 | |
| ZA928140B | South Africa | B | |
| IL111251D0 | Israel | D0 | |
| CA2173976A1 | Canada | A1 | |
| WO9510271A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CA2108963A1 | Canada | A1 | |
| AU7973794A | Australia | A | |
| WO9510271A3 | World Intellectual Property Organization (WIPO) | A3 | |
| ZA947964B | South Africa | B | |
| EP0567613A4 | European Patent Office (EPO) | A4 | |
| EP0725635A1 | European Patent Office (EPO) | A1 | |
| NZ244850A | New Zealand | A | |
| US5605930A | United States of America | A | |
| US5635532A | United States of America | A | |
| US5635533A | United States of America | A | |
| JPH09506079A | Japan | A | |
| US5654333A | United States of America | A | |
| US5661179A | United States of America | A | |
| US5708025A | United States of America | A | |
| US5710178A | United States of America | A | |
| US5712307A | United States of America | A | |
| US5843994A | United States of America | A | |
| US5852056A | United States of America | A | |
| AU702051B2 | Australia | B2 | |
| US5877213A | United States of America | A | |
| CA2108963C | Canada | C | |
| US5883124A | United States of America | A | |
| NZ270767A | New Zealand | A | |
| US6037376A | United States of America | A | |
| NZ275673A | New Zealand | A | |
| EP1108427A2 | European Patent Office (EPO) | A2 | |
| EP1108428A2 | European Patent Office (EPO) | A2 | |
| JP2001253821A | Japan | A | |
| EP1108428A9 | European Patent Office (EPO) | A9 | |
| EP0567613B1 | European Patent Office (EPO) | B1 | |
| AT213409T | Austria | T | |
| DE69232426D1 | Germany | D1 | |
| ES2171400T3 | Spain | T3 | |
| DE69232426T2 | Germany | T2 | |
| JP2003119130A | Japan | A | |
| EP1108427A3 | European Patent Office (EPO) | A3 | |
| EP1108428A3 | European Patent Office (EPO) | A3 | |
| IL111251A | Israel | A | |
| EP1484058A2 | European Patent Office (EPO) | A2 | |
| EP1484059A2 | European Patent Office (EPO) | A2 | |
| EP0725635B1 | European Patent Office (EPO) | B1 | |
| AT285760T | Austria | T | |
| DE69434211D1 | Germany | D1 | |
| JP3628694B2 | Japan | B2 | |
| HK1067551A1 | Hong Kong, China | A1 | |
| EP1484059A3 | European Patent Office (EPO) | A3 | |
| EP1523982A2 | European Patent Office (EPO) | A2 | |
| EP1484058A3 | European Patent Office (EPO) | A3 | |
| EP1523982A3 | European Patent Office (EPO) | A3 | |
| PT725635E | Portugal | E | |
| JP2005139208A | Japan | A | |
| JP2005139209A | Japan | A | |
| ES2233931T3 | Spain | T3 | |
| DE69434211T2 | Germany | T2 | |
| HK1077204A1 | Hong Kong, China | A1 | |
| CA2173976C | Canada | C | |
| EP1523982B1 | European Patent Office (EPO) | B1 | |
| AT388699T | Austria | T | |
| DE69435086D1 | Germany | D1 | |
| PT1523982E | Portugal | E | |
| DK1523982T3 | Denmark | T3 | |
| ES2303624T3 | Spain | T3 | |
| EP1484059B1 | European Patent Office (EPO) | B1 | |
| AT406883T | Austria | T | |
| DE69233743D1 | Germany | D1 | |
| SI1523982T1 | Slovenia | T1 | |
| DK1484059T3 | Denmark | T3 | |
| EP1484058B1 | European Patent Office (EPO) | B1 | |
| AT418975TThis record | Austria | T | |
| DE69233754D1 | Germany | D1 | |
| ES2312884T3 | Spain | T3 | |
| DE69435086T2 | Germany | T2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 4015994
Titles2
- German
- PHARMAZEUTISCHE ZUBEREITUNGEN ZUR BEHANDLUNG VON HEMOGLOBULINOPATHIEN DER BETA-CHAIN
- English
- PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF HEMOGLOBULINOPATHIES OF BETA-CHAIN
Classification
- CPC, 15
- A61K31/7076
- A61K31/19
- A61K31/192
- A61K31/20
- A61K31/35
- A61K31/365
- A61K31/70
- A61K31/7072
- A61K38/212
- A61K45/06
- A61P31/12
- A61P31/18
- A61P35/00
- A61P43/00
- A61P7/06
- IPC, 16
- A61K31 192
- A61K31 19
- A61K31 20
- A61K31 35
- A61K31 365
- A61K31 70
- A61K31 7072
- A61K31 7076
- A61K38 21
- A61K38 22
- A61K45 06
- A61P7 06
- A61P31 12
- A61P31 18
- A61P35 00
- A61P43 00